MEMORIAL SLOAN KETTERING CANCER CENTER and Quest Diagnostics announced a joint collaboration that will focus on gene mutations associated with solid tumors. Financial terms of the agreement were not disclosed.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe